Lifestyle changes to treat non-alcoholic fatty liver disease.
Official title: Complex Lifestyle Modification in the Treatment of Non-alcoholic Fatty Liver Disease
Run by General University Hospital, Prague · NCT05816915 · Data updated 2026-11-12
This study tests whether personalized lifestyle counseling can help people with non-alcoholic fatty liver disease improve their liver health better than standard care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | General University Hospital, Prague Academic / other |
| Locations | 1 site (Prague) |
| Status | Recruiting |
| Started | August 30, 2023 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | September 10, 2026 |
| Trial ID | NCT05816915 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals diagnosed with NAFLD who also have metabolic syndrome.
✕Probably not a fit
Patients with liver disease caused by factors other than NAFLD or those with uncontrolled cardiovascular disease may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project investigates the effects of personalized lifestyle counseling versus standard care on patients with non-alcoholic fatty liver disease (NAFLD) and metabolic syndrome. The study aims to evaluate changes in liver fat content and other health parameters over a one-year period. Participants will receive tailored cognitive behavioral therapy to promote lifestyle modifications, while researchers will also assess factors like gut microbiota that may influence the disease's progression or regression.
Why it matters
Potential benefit: If successful, this approach could lead to improved management and outcomes for patients with NAFLD and metabolic syndrome.
How similar studies have gone: While lifestyle modification has been suggested for NAFLD management, this specific approach of tailored counseling has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Individuals with NAFLD and metabolic syndrome Exclusion Criteria: * Etiology of liver disease other than NAFLD. * Presence of malignant disease. * Uncontrolled cardiovascular disease * Pregnancy.
Where it's running
-
General University Hospital
Prague, Czechia Recruiting
Study contacts
- Principal investigator: Radan Bruha, Prof. — General University Hospital, Prague
- Study coordinator: Radan Bruha, Prof.
- Email: bruha@cesnet.cz
- Phone: +420224962506
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Low‑methoxy pectin for inflammation, gut microbiome, and metabolic health in MASLD
This tests whether taking daily low‑methoxy pectin for six weeks can reduce inflammation and improve gut bacteria and metabolic markers in adults with MASLD.
-
Prospective NAFLD/NASH patient cohort and biobank
This project will collect medical data and blood/tissue samples from adults with NAFLD/NASH to create a long-term resource to help researchers understand disease course and causes.
-
Digital prevention for liver disease management
This study is testing a new way to help people with liver disease by using a mobile app for patients and a dashboard for doctors to see if it improves their care and health outcomes.
-
Using liver organoids to study non-alcoholic steatohepatitis
This study is trying to create mini-livers in the lab to see how different factors and genes affect the early stages of non-alcoholic steatohepatitis (NASH) in order to find new ways to track liver damage.
-
Examining Non-Alcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Disease
This study looks at how common Non-Alcoholic Fatty Liver Disease is in people with Inflammatory Bowel Disease to see how gut health might affect liver health.
-
Improving care for Veterans with non-alcoholic fatty liver disease
This study tests a new way to help Veterans with non-alcoholic fatty liver disease by using a structured plan to improve diagnosis and treatment compared to regular care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.